Protective effect of pre-operative conization in patients undergoing surgical treatment for early-stage cervical cancer

Gynecol Oncol. 2022 Jul;166(1):57-60. doi: 10.1016/j.ygyno.2022.05.014. Epub 2022 May 23.

Abstract

Objective: The aim of this study was to investigate the impact of pre-operative conization on disease-free survival (DFS) in early-stage cervical cancer.

Methods: In this population-based cohort study we analysed from clinical cancer registries to determine DFS of women with International Federation of Gynecology and Obstetrics (FIGO) stage IA1-IB1 cervical cancer with respect to conization preceding radical hysterectomy performed between January 2010 and December 2015.

Results: Out of 993 datasets available for the analysis, 235 patients met the inclusion criteria of the current study. The median follow-up was 5.4 years. During the study period, 28 (11.9%) recurrences were observed. All of these occurred in patients with FIGO stage IB1. For further evaluation, patients with FIGO IB1 tumors <2 cm were further analysed and divided into two groups, based on pre-operative conization. Pre-operative conization was associated with a reduced rate of recurrence (p = 0.007), with only three (5.2%) recurrences in this group (CO) compared to 25 recurrences (21.0%) in the group without conization (NCO) preceding radical hysterectomy. DFS was estimated at 79.0% and 94.8% in NCO and CO, respectively (p = 0.008). After adjustment for other prognostic covariates, conization remained a favourable prognostic factor for DFS (HR 0.27; 95% CI 0.08-0.93, p = 0.037). Lymph node involvement was the only unfavourable factor (HR 4.38; 95% CI 1.36-14.14, p = 0.014) in the multivariable analysis.

Conclusions: Pre-operative conization is associated with improved DFS in early-stage cervical cancer independently of the surgical approach.

Keywords: Cervical cancer; Conization; Radical hysterectomy; Recurrence.

MeSH terms

  • Cohort Studies
  • Conization* / methods
  • Female
  • Humans
  • Neoplasm Staging
  • Pregnancy
  • Recurrence
  • Uterine Cervical Neoplasms* / pathology